The largest database of trusted experimental protocols

Acylase

Manufactured by Merck Group
Sourced in United States

Acylase is a laboratory enzyme used to catalyze the hydrolysis of acyl groups from various substrates. It functions by breaking down the chemical bonds in acyl compounds, facilitating their separation and analysis.

Automatically generated - may contain errors

2 protocols using acylase

1

Enzymatic Assay Development for Pancreatitis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the chemicals and reagents were commercially available and used as received without further purification. Superdry tetrahydrofuran (THF) was purchased from J&K Scientific. Titanium tetrachloride (TiCl4), 4-dimethylaminopyridine (DMAP), 4-hydroxybenzophenone, and n-butyllithium were purchased from Aldrich. Dicyclohexylcarbodiimide (DCC), p-toluene sulfonic acid (PTSA) monohydrate, and Boc-l-glutamic acid 1-tert-butyl ester (Boc-Glu-OtBu) were purchased from Acros Organics. Lipases from Pseudomonas cepacia (PCL), Candida rugosa (CRL), Candida Antarctica B (CALB), Pseudomonas fluorescens (PFL), Porcine pancreas (PPL), and Aspergillus niger (ANL) were all ordered from Amano Enzymes. Glucose oxidase, alkaline phosphatase, acylase, laccase, and α-amylase were all purchased from Sigma-Aldrich. The Lipase Assay Kit was purchased from the Nanjing Jiancheng Bioengineering Institute. The human serum samples were supplied by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, and the serum samples were from both healthy people and acute pancreatitis patients. The water used in the tests was triple distilled, treated with an ion exchange column, and then treated with a Milli-Q water purification system.
+ Open protocol
+ Expand
2

Multispecies Consortium Biofilm Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
A consortium composed of Acinetobacter sp. YS01, Bacillus sp. AS03, Escherichia coli, Enterobacter sp. YS02, Sphingobium xanthum, Sphingopyxis sp. NM1, Microbacterium sp. NM2, Staphylococcus warneri, and Xanthomonas translucens was used as an inoculum. The different daily acylase treatment episodes are shown in Table S2. One hundred microliters of the consortium, with or without acylase (Sigma-Aldrich, USA; final concentration of 10 mg/l), was inoculated onto the bottom of a plate. The plate was incubated at 25°C with agitation at 40 rpm for 5 days, during which the suspension was replaced daily with the same volume of fresh LS-R2A medium with or without acylase (final concentration, 10 mg/l). There were three replicates per each treatment.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!